Class 0 (HCN channel blockers) |
Ivabradine |
Class I (voltage-gated Na+ channel blockers) |
Class Ia (intermediate dissociation): |
|
Class Ib (rapid dissociation): |
|
Class Ic (slow dissociation): |
|
Class Id (late current): |
|
Class II (autonomic inhibitors and activators) |
Class IIa (beta blockers): |
|
|
Class IIb (nonselective beta agonists): |
|
Class IIc (muscarinic M2 receptor inhibitors): |
|
Class IId (muscarinic M2 receptor activators): |
|
Class IIe (adenosine A1 receptor activators): |
|
Class III (K+ channel blockers and openers) |
Class IIIa (voltage dependent K+ channel blockers): |
|
Class IIIb (metabolically dependent K+ channel openers): |
|
Class IV (Ca++ handling modulators) |
Class IVa (surface membrane Ca++ channel blockers): |
|
Class IVb (intracellular Ca++ channel blockers): |
|
Class V (mechanosensitive channel blockers): |
No approved medications |
Class VI (gap junction channel blockers) |
No approved medications |
Class VII (upstream target modulators) |
Angiotensin converting enzyme inhibitors |
Angiotensin receptor blockers |
Omega-3 fatty acids |
Statins |
Do you want to add Medilib to your home screen?